Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 7
2005 6
2006 5
2007 14
2008 11
2009 28
2010 23
2011 19
2012 22
2013 23
2014 25
2015 20
2016 24
2017 36
2018 27
2019 35
2020 48
2021 45
2022 48
2023 53
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

494 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Is the axiom of balloon angioplasty, "the more you gain the more you lose", still true in the era of DCB with paclitaxel?
Serruys PW, Tobe A, Ninomiya K, Garg S, Finn AV, Scheller B, Cortese B, Colombo A, Reimers B, Basavarajaiah S, Sharif F, Fezzi S, Gao C, Tao L, Onuma Y. Serruys PW, et al. Among authors: tao l. Cardiovasc Revasc Med. 2024 Apr 6:S1553-8389(24)00144-1. doi: 10.1016/j.carrev.2024.04.001. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 38664133
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial.
Li X, Ge Z, Kan J, Anjum M, Xie P, Chen X, Khan HS, Guo X, Saghir T, Chen J, Gill BUA, Guo N, Sheiban I, Raza A, Wei Y, Chen F, Mintz GS, Zhang JJ, Stone GW, Chen SL; IVUS-ACS Investigators. Li X, et al. Lancet. 2024 Apr 5:S0140-6736(24)00282-4. doi: 10.1016/S0140-6736(24)00282-4. Online ahead of print. Lancet. 2024. PMID: 38604212
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
Ge Z, Kan J, Gao X, Raza A, Zhang JJ, Mohydin BS, Gao F, Shao Y, Wang Y, Zeng H, Li F, Khan HS, Mengal N, Cong H, Wang M, Chen L, Wei Y, Chen F, Stone GW, Chen SL; ULTIMATE-DAPT investigators. Ge Z, et al. Lancet. 2024 Apr 5:S0140-6736(24)00473-2. doi: 10.1016/S0140-6736(24)00473-2. Online ahead of print. Lancet. 2024. PMID: 38599220
494 results